176 related articles for article (PubMed ID: 9054837)
1. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.
Hornig B; Kohler C; Drexler H
Circulation; 1997 Mar; 95(5):1115-8. PubMed ID: 9054837
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
Hornig B; Arakawa N; Haussmann D; Drexler H
Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
[TBL] [Abstract][Full Text] [Related]
3. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
Haefeli WE; Linder L; Lüscher TF
Hypertension; 1997 Oct; 30(4):912-7. PubMed ID: 9336392
[TBL] [Abstract][Full Text] [Related]
4. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
Hornig B; Kohler C; Schlink D; Tatge H; Drexler H
Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
[TBL] [Abstract][Full Text] [Related]
5. Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.
Benacerraf S; Carville C; Adnot S; Montagne O; Sediame S; Belhassen L; Dubois-Randé JL
J Cardiovasc Pharmacol; 1999 Sep; 34(3):368-73. PubMed ID: 10470994
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
Hecker M; Bara AT; Busse R
Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
[TBL] [Abstract][Full Text] [Related]
8. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men.
Squire IB; O'Kane KP; Anderson N; Reid JL
Hypertension; 2000 Jul; 36(1):132-6. PubMed ID: 10904025
[TBL] [Abstract][Full Text] [Related]
11. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Zanzinger J; Zheng X; Bassenge E
Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
[TBL] [Abstract][Full Text] [Related]
13. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ
N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144
[TBL] [Abstract][Full Text] [Related]
14. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Hornig B; Arakawa N; Drexler H
Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
Cockcroft JR; Chowienczyk PJ; Brett SE; Bender N; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):317-21. PubMed ID: 7833220
[TBL] [Abstract][Full Text] [Related]
16. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
17. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
Prasad A; Husain S; Quyyumi AA
J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
[TBL] [Abstract][Full Text] [Related]
18. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
Persson K; Andersson RG
J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
20. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]